ASSOCIATION BETWEEN PROTECTIVE EFFICACY OF ANTIBODIES TO TUMOR-NECROSIS-FACTOR AND SUPPRESSION OF NITRIC-OXIDE PRODUCTION IN NEONATAL RATS WITH FATAL INFECTION
Citation
Y. Shi et al., ASSOCIATION BETWEEN PROTECTIVE EFFICACY OF ANTIBODIES TO TUMOR-NECROSIS-FACTOR AND SUPPRESSION OF NITRIC-OXIDE PRODUCTION IN NEONATAL RATS WITH FATAL INFECTION, Pediatric research, 34(3), 1993, pp. 345-348
Categorie Soggetti
Pediatrics
SICI code
0031-3998(1993)34:3<345:ABPEOA>2.0.ZU;2-J
Abstract
In a rat model of fatal infection caused by Pseudomonas aeruginosa, th
e circulating level of nitrite/nitrate (NO2-/NO3-), a good indicator f
or nitric oxide production, was remarkably increased after elevation o
f circulatory tumor necrosis factor (TNF). Anti-TNF MAb cotreatment wa
s shown to blunt hypoglycemia and hyperlacticemia and was associated w
ith decreased mortality of septic animals. Moreover, anti-TNF MAb sign
ificantly reduced not only plasma TNF but also plasma NO2-/NO3- levels
. Dexamethasone had a similar effects, and when anti-TNF MAb was used
in combination with dexamethasone, the suppression of nitric oxide pro
duction and the protective efficacy were more remarkable compared with
therapy with either anti-TNF MAb or dexamethasone alone. Our present
data suggested that the protective efficacy of anti-TNF MAb may correl
ate with the suppression of nitric oxide production and also with a mo
dulation in metabolic abnormalities in the septic newborn rats.